Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta.
Jannie D HaldCatriona KeerieChristopher J WeirMuhammad K JavaidWayne LamPatricia OsborneJennifer WalshBente Lomholt LangdahlStuart H RalstonPublished in: BMJ open (2023)
ISRCTN15313991.